ask="N/A"
ask_size="N/A"
average_daily_volume="31514"
bid="3.00"
bid_size="1000"
book_value="3.34"
change="-0.02"
change_from_200_day_moving_average="1.84"
change_from_50_day_moving_average="2.19"
change_from_52_week_high="-1.36"
change_From_52_week_low="4.91"
change_in_percent="-0.24%"
close="8.43"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.60"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.85"
ex_dividend_date="N/A"
float_shares="686000"
high="8.60"
high_52_weeks="9.79"
last_trade_date="1/27/2017"
last_trade_price="8.43"
last_trade_size="100"
last_trade_time="3:59pm"
low="8.05"
low_52_weeks="3.52"
market_capitalization="179.39M"
moving_average_200_day="6.59"
moving_average_50_day="6.24"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="16.24"
open="8.57"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+27.90%"
percent_change_from_50_day_moving_average="+35.05%"
percent_change_from_52_week_high="-13.87%"
percent_change_from_52_week_low="+139.49%"
previous_close="8.45"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.53"
price_per_sales="34.58"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="4.80"
stock_exchange="NMS"
symbol="NBRV"
volume="21436"
weeks_range_52="3.52 - 9.79"
